This ongoing triple-blind, randomized controlled crossover trial investigates the effects of a single ingestion of KE (ketone esters) on signs and symptoms of schizophrenia spectrum disorders (SSDs) and bipolar disorders (BDs).
Sign up for the Metabolic Mind newsletter for regular updates in your inbox. Sign Up